Hainan Huluwa Pharmaceutical (SHA:605199) controlling shareholder Hainan Huluwa Investment Development unfroze 17 million shares, according to a Tuesday filing with the Shanghai bourse.
Huluwa Investment could use the unfrozen shares for pledging.
The shareholder still has 8 million frozen shares.